54.34
price down icon2.34%   -1.30
after-market Handel nachbörslich: 53.70 -0.64 -1.18%
loading

Nektar Therapeutics Aktie (NKTR) Neueste Nachrichten

pulisher
06:05 AM

Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - MSN

06:05 AM
pulisher
Oct 11, 2025

Wealth Enhancement Advisory Services LLC Reduces Stake in Nektar Therapeutics $NKTR - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

Nektar Therapeutics' (NKTR) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What MACD and RSI say about Nektar TherapeuticsJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Evaluating Nektar Therapeutics with trendline analysisJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail

Oct 09, 2025
pulisher
Oct 09, 2025

How Nektar Therapeutics (ITH0) stock responds to job market shiftsNew Guidance & Reliable Price Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Sector ETF performance correlation with Nektar Therapeutics2025 Technical Patterns & AI Driven Price Predictions - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Quantitative breakdown of Nektar Therapeutics recent moveJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Gainplan LLC Buys New Shares in Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Public Employees Retirement System of Ohio Sells 121,001 Shares of Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Nektar Therapeutics (NKTR): Examining Valuation After Breakthrough Eczema Drug Trial Results Spark Investor Interest - Sahm

Oct 07, 2025
pulisher
Oct 06, 2025

How Nektar Therapeutics (ITH0) stock reacts to weak economyDividend Hike & Real-Time Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Nektar Therapeutics stockSwing Trading Watchlist & Build Wealth With Expert Timing Advice - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Real time social sentiment graph for Nektar TherapeuticsTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is a relief rally coming for Nektar Therapeutics holdersTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

How analysts rate Nektar Therapeutics stock today2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Nektar Therapeutics (NKTR) Is Up 8.8% After Positive Phase 2b Rezpegaldesleukin Data at EADV - simplywall.st

Oct 03, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics (NASDAQ:NKTR) Reaches New 52-Week HighTime to Buy? - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

The biotech scorecard for the fourth quarter: 36 stock-moving events to watch - statnews.com

Oct 02, 2025
pulisher
Oct 02, 2025

BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛

Oct 02, 2025
pulisher
Oct 01, 2025

Building trade automation scripts for Nektar TherapeuticsJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Voya Investment Management LLC Raises Stock Holdings in Nektar Therapeutics $NKTR - MarketBeat

Oct 01, 2025
pulisher
Sep 29, 2025

Diffuse Large B Cell Lymphoma Pipeline Drugs Report 2025: Tracking Novel Therapies, Competitive Scenarios, and R&D Innovations Across Key Indications - Barchart.com

Sep 29, 2025
pulisher
Sep 29, 2025

Metastatic Renal Cell Carcinoma Pipeline 2025: Pioneering Clinical Developments by 40+ Global Leaders – DelveInsight | Novartis Pharmaceuticals, Vaccibody, SillaJen, Chongqing Precision Biotech - Barchart.com

Sep 29, 2025
pulisher
Sep 28, 2025

Nektar Therapeutics Hits New 52-Week High of $61.06, Up 229.74% - Markets Mojo

Sep 28, 2025
pulisher
Sep 28, 2025

Goldman Sachs Group Inc. Decreases Position in Nektar Therapeutics $NKTR - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Parallel Advisors LLC Sells 14,767 Shares of Nektar Therapeutics $NKTR - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Should you hold or exit Nektar Therapeutics nowJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com

Sep 28, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):